共 8 条
- [1] The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. Parving HH,Lehnert H,Brochner-Mortensen J,et al. The New England Journal of Medicine . 2001
- [2] Insitute blood glucose control with sulphonyl-ureas or insulin compared with conventional risk of complication in patient with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study Group. The Lancet . 1998
- [3] Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus. Molnar M,Wittmann I,Nagy J. Medical Science Monitor . 2000
- [4] Tight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes. UK Prospective Diabetes Study Group. British Medical Journal . 1998
- [5] The rising global burden of diabetes and its complications: estimates and projection to the year 2010. Amos AF,McCarty PJ,Zimmet PJ. Diabetic Medicine .
- [6] Risk of macrovascular and microvascular complications in Type 2 diabetes: results of longitudinal study design. Nazimek-Siewniak B,Moczulski D,Grzeszczak W. Diabetes Complications . 2002
- [7] Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels,mean blood pressure, and hyperglycemia. Ravid M,Brosh D,Ravid-Safran D,et al. Archives of Internal Medicine . 1998
- [8] The zuoker rat model of obesity , insulin resistance, hperlipidemia, and renal injury. Kasiske BL,O Dennel MP. Journal of Hypertension . 1992